Radius Health (NASDAQ: RDUS) announced positive top-line data from the first six months of the ACTIVExtend trial that showed women ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE